Top Markets
Coin of the day
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
주식 순위 #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
주가
$0.01904982
마지막 동기화: 2023-05-19
시가총액
$316.00K
변동 (1일)
-17.05%
변동 (1년)
0.00%
국가
GB
거래 OKYO Pharma Limited (OKYO)

카테고리

OKYO Pharma Limited (OKYO)의 주가 이력
최고 종가: $0.02 (2023-05-01 기준)

최저 종가: $0.07 (2018-07-01 기준)
OKYO Pharma Limited의 주가 이력 (2018 ~ 2026)
연간 주가 성과
연도 성과
2023 -21.40%
2022 -68.15%
2021 -2.30%
2020 334.44%
2019 25.96%
2018 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.40%
KR
$259.89 14.81%
BE